Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Arm-Cuff trick may shield diabetic kidneys from dye damage

NCT ID NCT07179874

First seen Oct 31, 2025 · Last updated Jun 23, 2026 · Updated 34 times

Summary

This study tested whether a non-invasive technique called remote ischemic preconditioning (RIPC) can prevent kidney damage caused by contrast dye used in heart imaging. The procedure involves briefly inflating a blood pressure cuff on the arm to restrict blood flow in cycles. Researchers studied 71 diabetic patients at high risk for kidney injury. The goal was to see if RIPC reduces oxidative stress and protects kidney function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONTRAST-INDUCED ACUTE KIDNEY INJURY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Remote Ischemic Preconditioning (a procedure using a blood pressure cuff to briefly restrict arm blood flow)

What this could lead to

If it works, this could provide a simple, non-invasive way to prevent kidney damage in diabetic patients undergoing heart imaging procedures.

What could go wrong

This is a small, completed study with only 71 participants. The technique may not work as well in diabetic patients due to their altered metabolism, and results need confirmation in larger trials.

Conditions

The condition(s) this trial relates to.

acute coronary syndrome diabetes mellitus acute kidney injury prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.